These aren't happy times for the pharmaceutical industry. Day by day, bad news accumulates, and even the Pharmaceutical Research and Manufacturers Association (PhRMA), the industry's trade organization, acknowledges that something has to give:
FDA warns of serious potential reaction to levetiracetam and clobazam
November 30th 2023The reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), can start as a rash but can progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.